Login / Signup

Adverse publicity of serious side effects to healthy volunteers has limited effect on willingness-to-participate in clinical trials.

Nicolas MolinariCarey Meredith SuehsIsabelle VachierLaurie PahusLaurence HalimiAnne-Sophie GamezPascal ChanezArnaud Bourdin
Published in: Clinical trials (London, England) (2019)
Keyphrases
  • clinical trial
  • phase ii
  • open label
  • electronic health record